Remove Ethics Remove Innovation Remove Pharmaceuticals Remove Productivity
article thumbnail

The Ethical Complications Of Electronic Pills

The Horizons Tracker

The growth in electronic medicines offers significant potential to better monitor the effectiveness of treatments, but new research from the University of Copenhagen also highlights the ethical and legal complications the technology brings. It is important that the public have confidence in the product. New capabilities.

Ethics 66
article thumbnail

Is Consumer Non-Durables a Good Career Path?

Talent Anarchy 1

Consumer non-durables refer to products that have a relatively short lifespan, like food, beverages, and personal care items. These products are a staple in every household and are consumed daily, making them a constant presence in our lives. Pharmaceuticals: Medicines and healthcare products are also considered consumer non-durables.

Career 78
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Guest Post: Talk is Cheap!

Lead on Purpose

Over 150 companies, including Durkee, Cremora, San Giorgio, Ronzoni, and McCormick, now use the entire line of Flapper products, and Weatherchem continues to lead the industry in offering the widest, most innovative array of closure products.

Committee 140
article thumbnail

Conflict-of-Interest Rules Are Holding Back Medical Breakthroughs

Harvard Business Review

Few issues are more foundational to driving improvements in human health than creating productive, progressive relationships between clinical medicine and the biopharmaceutical industry. How the most innovative providers are creating value. Insight Center. The Leading Edge of Health Care. Sponsored by Optum. Practicing physicians.

article thumbnail

Big Pharma's Hidden Business Model and How Your Company Funds It

Harvard Business Review

The study assembles considerable evidence about the hidden business model of major pharmaceutical companies: to devote most of their research budget to developing hundreds of drugs that provide few if any advantages over existing drugs and then market them heavily to doctors and patients. Negative results are usually not published at all.

article thumbnail

Autism's Competitive Advantage, and Challenge, in the Workplace

Harvard Business Review

SAP, the German software giant, announced that it hopes to hire hundreds of autistics as talented programmers and product testers. SAP''s Bangalore office saw its productivity increase after deploying autistic hires. The firm told the BBC that by 2020 perhaps 1% of its global workforce of 65,000 would be people with autism.

article thumbnail

How Merck Is Trying to Keep Disrupters at Bay

Harvard Business Review

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products.